InsiderTrades.com logo

NIOX Insider Trading

Insider Ownership Percentage: 4.89%
Insider Buying (Last 12 Months): £45,614.98
Insider Selling (Last 12 Months): £4,335,860.75

NIOX Group Insider Trading History Chart

This chart shows the insider buying and selling history at NIOX Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NIOX Group Share Price & Price History

Current Price: GBX 69
Price Change: ▼ Price Decrease of -2.4 (-3.36%)
As of 12/5/2025 04:39 AM ET

This chart shows the closing price history over time for NIOX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

NIOX Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/3/2025Sarah DuncanInsiderBuy5,522GBX 71£3,920.62
6/25/2025Ian JohnsonInsiderBuy144,844GBX 8£11,587.52
5/20/2025Ian JohnsonInsiderSell3,924,630GBX 65£2,551,009.50
5/20/2025Jonathan EmmsInsiderSell2,745,925GBX 65£1,784,851.25
4/1/2025Jonathan EmmsInsiderBuy127,454GBX 8£10,196.32
12/18/2024Jonathan EmmsInsiderBuy31,604GBX 63£19,910.52
10/25/2024Garry WattsInsiderSell27,109GBX 80£21,687.20
6/25/2024Michael R D RollerInsiderBuy60,000GBX 68£40,800
4/5/2024Michael R D RollerInsiderSell30,000GBX 64£19,200
4/3/2024Jonathan EmmsInsiderSell31,250GBX 64£20,000
3/28/2024Ian JohnsonInsiderSell223,784GBX 62£138,746.08
3/28/2023Jonathan EmmsInsiderSell227,439GBX 44£100,073.16
See Full Table

SEC Filings (Institutional Ownership Changes) for NIOX Group (LON:NIOX)

7.56% of NIOX Group stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

NIOX Group logo
NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings. Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries. NIOX is committed to enabling more precise and personalised care for patients with respiratory conditions, with a focus on quality, innovation, and scientific excellence.
Read More on NIOX Group

Today's Range

Now: GBX 69
Low: 69
High: 69

50 Day Range

MA: GBX 71.28
Low: 65.73
High: 76

52 Week Range

Now: GBX 69
Low: 53.40
High: 77.60

Volume

496,533 shs

Average Volume

1,100,417 shs

Market Capitalization

£288.34 million

P/E Ratio

55.20

Dividend Yield

1.75%

Beta

0.92

Who are the company insiders with the largest holdings of NIOX Group?

NIOX Group's top insider shareholders include:
  1. Garry Watts (Insider)
  2. Ian Johnson (Insider)
  3. Jonathan Emms (Insider)
  4. Michael R D Roller (Insider)
  5. Sarah Duncan (Insider)
Learn More about top insider investors at NIOX Group.